LU83556A1 - Nouvelles compositions pharmaceutiques contenant de l'almitrine - Google Patents

Nouvelles compositions pharmaceutiques contenant de l'almitrine Download PDF

Info

Publication number
LU83556A1
LU83556A1 LU83556A LU83556A LU83556A1 LU 83556 A1 LU83556 A1 LU 83556A1 LU 83556 A LU83556 A LU 83556A LU 83556 A LU83556 A LU 83556A LU 83556 A1 LU83556 A1 LU 83556A1
Authority
LU
Luxembourg
Prior art keywords
almitrine
doses
respiratory
ventilation
blood
Prior art date
Application number
LU83556A
Other languages
English (en)
French (fr)
Inventor
Etienne Labeyrie
Jean P Poirier
Francoise Arnaud
Original Assignee
Science Union & Cie
Medicale Rech France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Science Union & Cie, Medicale Rech France filed Critical Science Union & Cie
Publication of LU83556A1 publication Critical patent/LU83556A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU83556A 1980-08-18 1981-08-14 Nouvelles compositions pharmaceutiques contenant de l'almitrine LU83556A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8018074 1980-08-18
FR8018074A FR2488509A1 (fr) 1980-08-18 1980-08-18 Nouvelles compositions pharmaceutiques contenant de l'almitrine

Publications (1)

Publication Number Publication Date
LU83556A1 true LU83556A1 (fr) 1982-04-14

Family

ID=9245242

Family Applications (1)

Application Number Title Priority Date Filing Date
LU83556A LU83556A1 (fr) 1980-08-18 1981-08-14 Nouvelles compositions pharmaceutiques contenant de l'almitrine

Country Status (14)

Country Link
US (1) US4364946A (Direct)
AU (1) AU550741B2 (Direct)
BE (1) BE890011A (Direct)
CA (1) CA1181694A (Direct)
CH (1) CH650152A5 (Direct)
DE (1) DE3132654A1 (Direct)
FR (1) FR2488509A1 (Direct)
GB (1) GB2082064B (Direct)
GR (1) GR75328B (Direct)
IE (1) IE52095B1 (Direct)
IT (1) IT1171461B (Direct)
LU (1) LU83556A1 (Direct)
NZ (1) NZ198062A (Direct)
ZA (1) ZA815664B (Direct)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2660558B1 (fr) * 1990-04-05 1994-09-09 Adir Utilisation de l'almitrine pour l'obtention de medicaments destines au traitement du paludisme.
US8453522B2 (en) * 2009-07-31 2013-06-04 Mts Systems Corporation Wind turbine drive train test assembly
NZ756012A (en) 2017-01-17 2025-10-31 Michael David Forrest Therapeutic inhibitors of the reverse mode of atp synthase
JP2021510365A (ja) * 2017-07-13 2021-04-22 デイヴィッド フォレスト マイケル Ａｔｐシンターゼの逆モードの治療的モジュレーター

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1256513A (Direct) * 1968-10-02 1971-12-08

Also Published As

Publication number Publication date
AU550741B2 (en) 1986-04-10
AU7427781A (en) 1982-02-25
ZA815664B (en) 1982-08-25
US4364946A (en) 1982-12-21
GB2082064B (en) 1985-06-26
CH650152A5 (fr) 1985-07-15
FR2488509A1 (fr) 1982-02-19
IE811891L (en) 1982-02-18
GB2082064A (en) 1982-03-03
NZ198062A (en) 1983-12-16
IT8149104A1 (it) 1983-02-13
FR2488509B1 (Direct) 1984-11-23
IT8149104A0 (it) 1981-08-13
BE890011A (fr) 1982-02-18
CA1181694A (fr) 1985-01-29
GR75328B (Direct) 1984-07-13
IE52095B1 (en) 1987-06-10
DE3132654A1 (de) 1982-06-24
IT1171461B (it) 1987-06-10

Similar Documents

Publication Publication Date Title
Clark et al. Sleep apnea: treatment with protriptyline
Kannel et al. Atherosclerosis as a pediatric problem
Wang et al. Glucose metabolism in pig outer retina in light and darkness
Kryger et al. The sleep deprivation syndrome of the obese patient: a problem of periodic nocturnal upper airway obstruction
Turhanoğlu et al. Effects of different doses of oral ketamine for premedication of children
Carrive et al. Orexin and central modulation of cardiovascular and respiratory function
CA2001572C (en) Compositions for treating tobacco withdrawal symptoms
JP5902148B2 (ja) 自閉症治療用ジメチルスルホキシド（ｄｍｓｏ）製剤
Reeves et al. Early postnatal chronic intermittent hypoxia modifies hypoxic respiratory responses and long-term phrenic facilitation in adult rats
US20140271890A1 (en) Controlled-release pharmaceutical composition
US6436946B1 (en) Xanthine-containing compositions for oral administration and uses related thereto
LU83556A1 (fr) Nouvelles compositions pharmaceutiques contenant de l'almitrine
Weil Sleep at high altitude
Alipour et al. Comparison of tadalafil and sildenafil in controlling neonatal persistent pulmonary hypertension
Lehtonen et al. Doxazosin effects on insulin and glucose in hypertensive patients
US20200155553A1 (en) Arterial Oxygen Saturation Degree Improver
WO2005002602A2 (en) Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus and insulin resistance
US10238684B2 (en) Micro- and nano-quantity sleep enhancing nutrient composition and method of enhancing central nervous system protein clearance using same
EP1767200A1 (en) Antiaging agent
US20030165585A1 (en) Xanthine-containing compositions for oral administration and uses related thereto
KR100740079B1 (ko) 당뇨병성 신경 장해용 의약 조성물
FR2922109A1 (fr) Composition pharmaceutique ou dietetique pour inhiber l'absorption intestinale du sucre.
US20200085849A1 (en) Methods and compositions for improving sleep
US20160296491A1 (en) Compositions and methods for treatment of movement disorders
KAFER et al. Respiratory and cardiovascular responses to hypoxemia and the effects of anesthesia